Neoral C 2 monitoring in pediatric liver transplant recipients

By Dunn S.   Falkenstein K.   Cooney G.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3094-3095

Elsevier

Access to resources Recommend Favorite

Benefits of cyclosporine microemulsion (Neoral) C 2 monitoring are sustained at 1 year in de novo liver transplant recipients

By Lake J.R.   Neo-INT-06 Study Group  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3092-3093

Elsevier

Access to resources Recommend Favorite

Neoral (cyclosporine) C 2 monitoring in renal transplant recipients: a single-center experience in Asia

By Wong H.-S.   Morad Z.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 230-231

Elsevier

Access to resources Recommend Favorite

Single-center study utilizing C 2 level as monitoring tool in de novo renal transplant recipients treated with neoral

By Keshavamurthy M.   Al Ahmadi I.   Mohammed Raza S.   Baynton R.   Al Meshari K.   Al Shaibani K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3112-3114

Elsevier

Access to resources Recommend Favorite

Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients

By Zylber-Katz E.   Doron D.   Granot E.  

Transplantation Proceedings, Vol. 31, Iss. 4, 1999-06 ,pp. : 1915-1917

Elsevier

Access to resources Recommend Favorite